These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26666921)

  • 1. Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.
    Dafopoulou K; Xavier BB; Hotterbeekx A; Janssens L; Lammens C; Dé E; Goossens H; Tsakris A; Malhotra-Kumar S; Pournaras S
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1892-5. PubMed ID: 26666921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
    Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.
    Sato Y; Unno Y; Ubagai T; Ono Y
    PLoS One; 2018; 13(3):e0194556. PubMed ID: 29554105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.
    Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ
    Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
    Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
    Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm Formation and Colistin Susceptibility of Acinetobacter baumannii Isolated from Korean Nosocomial Samples.
    Kim HA; Ryu SY; Seo I; Suh SI; Suh MH; Baek WK
    Microb Drug Resist; 2015 Aug; 21(4):452-7. PubMed ID: 25714496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.
    Parra-Millán R; Vila-Farrés X; Ayerbe-Algaba R; Varese M; Sánchez-Encinales V; Bayó N; Pachón-Ibáñez ME; Teixidó M; Vila J; Pachón J; Giralt E; Smani Y
    J Antimicrob Chemother; 2018 Dec; 73(12):3405-3412. PubMed ID: 30188994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.
    Hood MI; Becker KW; Roux CM; Dunman PM; Skaar EP
    Infect Immun; 2013 Feb; 81(2):542-51. PubMed ID: 23230287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy against extensively drug-resistant Acinetobacter baumannii in vitro by two old antibiotics: colistin and chloramphenicol.
    Wei WJ; Yang HF
    Int J Antimicrob Agents; 2017 Mar; 49(3):321-326. PubMed ID: 28167347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment.
    Kim Y; Bae IK; Jeong SH; Yong D; Lee K
    Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
    Wei W; Yang H; Hu L; Ye Y; Li J
    J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Different Resistance Mechanisms and Virulence in
    Espinal P; Pantel A; Rolo D; Marti S; López-Rojas R; Smani Y; Pachón J; Vila J; Lavigne JP
    Microb Drug Resist; 2019 Jun; 25(5):752-760. PubMed ID: 30632884
    [No Abstract]   [Full Text] [Related]  

  • 15. Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment.
    Soon RL; Nation RL; Cockram S; Moffatt JH; Harper M; Adler B; Boyce JD; Larson I; Li J
    J Antimicrob Chemother; 2011 Jan; 66(1):126-33. PubMed ID: 21081544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.
    He X; Lu F; Yuan F; Jiang D; Zhao P; Zhu J; Cheng H; Cao J; Lu G
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4817-25. PubMed ID: 26033730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
    Cai Y; Wang R; Liang BB; An MM
    J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
    [No Abstract]   [Full Text] [Related]  

  • 19. Colistin Dependence in Extensively Drug-Resistant
    Chamoun S; Welander J; Martis-Thiele MM; Ntzouni M; Claesson C; Vikström E; Turkina MV
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.